Syndax Pharmaceuticals
Markets targeted therapies for acute leukemias and chronic graft-versus-host disease.
$19.39
After-hours close−0.15 (−0.77%)
At close$19.54(−3.08%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.51 | — | — |
| Aug 2026 | −$0.45 | −$0.55 | −22.9% |
| Apr 2026 | −$0.59 | −$0.48 | +18.6% |
| Feb 2026 | −$0.58 | −$0.78 | −33.6% |
| Nov 2025 | −$0.74 | −$0.70 | +5.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | −$0.51 | — | — | $82.8M | — | — |
| Aug 4, 2026 | −$0.45 | −$0.55 | −22.9% | $79.4M | $72.8M | −8.3% |
| Apr 30, 2026 | −$0.59 | −$0.48 | +18.6% | $69.8M | $64.9M | −7.0% |
| Feb 26, 2026 | −$0.58 | −$0.78 | −33.6% | $64.3M | $68.7M | +6.9% |
| Nov 3, 2025 | −$0.74 | −$0.70 | +5.4% | $63.3M | $45.9M | −27.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 4, 2025 | ||||||
| May 5, 2025 | ||||||
| Mar 3, 2025 | ||||||
| Nov 5, 2024 | ||||||
| Aug 1, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 8, 2022 | ||||||
| May 9, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 15, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 11, 2021 | ||||||
| Mar 8, 2021 | ||||||
| Nov 2, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 3, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 6, 2019 | ||||||
| Mar 7, 2019 | ||||||
| Nov 5, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 5, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 10, 2017 | ||||||
| May 8, 2017 | ||||||
| Mar 2, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 16, 2016 | ||||||
| Mar 3, 2016 | ||||||
| Dec 31, 2015 | ||||||
| Jun 30, 2015 | ||||||